Michael DeMane is listed as an executive officer and director on 14 SEC Form D filings by 5 issuers between Sep 2009 and Feb 2020: NEVRO CORP (Menlo Park, CA — biotechnology — 2011; $58.6M reported sold to 13 investors), TORAX MEDICAL INC (Shoreview, MN — biotechnology — 2011–2012; $25M reported sold to 17 investors), Cardionomic, Inc. (New Brighton, MN — other health care — 2015–2020; $21.8M reported sold to 12 investors), ROTATION MEDICAL INC (Plymouth, MN — other health care — 2009–2016; $21.7M reported sold to 14 investors) and Denali Medical II, Inc. (Plymouth, MN — biotechnology — 2010; $4M reported sold to 1 investors).
What this means A repeat sponsor — 5 separate companies raised money with this person listed as executive officer and director, over about 11 years. Across those companies the filings report $131.2M sold in total.
Listed alongside Ali Behbahani (9 shared filings), Albert Graf (6 shared filings), John Nehra (6 shared filings), Thomas A. Westling (5 shared filings), Craig Van Kampen (4 shared filings) and 35 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.
2 of the issuers belong to the sponsor group Rotation (2 issuers, $12M reported sold, 2009–2016).
What this means A sponsor group is one team that sets up a new company for each deal. Rotation has 2 companies on file and $12M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 court case matching the name, 1 SEC release listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 14 public filings for Michael DeMane and found 14 differences, 1 worth asking the sponsor about: Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.